Health Canada monitors compliance of health products on the market in various ways. One way is through the regular Good Pharmacovigilance Practices (GVP) inspection that verifies how the regulated parties meet the requirements under the Food and Drug Regulations. One additional way is through proactive compliance monitoring projects (CMPs). This session will focus on the ongoing initiatives in these programs and will give an overview of the current practices and perspectives of both industry and regulatory authorities.
LearningObjective-At the conclusion of this session, participants should be able to:
Differentiate between GVP regular inspections and proactive monitoring projects
Discuss what is expected during Health Canada‘s GVP inspections and proactive CMPs including current and future approaches for virtual inspections
Identify the current and potential future GVP projects and proactive CMPs